首頁 > 市場調查報告書 > 製藥

臨床開發

全球小鼠模型技術市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

市場調查報告書

商品編碼

1342841

全球小鼠模型技術市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Mice Model Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球小鼠模型技術市場需求預計將從 2022 年的 50.4 億美元增至 2030 年的近 125.2 億美元，2023-2030 年研究期間年複合成長率為 10.64%。

小鼠模型技術使用不同的小鼠物種來模擬人類發現的生物過程或疾病的特徵。這些技術之所以變得流行，是因為小鼠與人類具有哺乳動物的特徵，並且患有許多類似的疾病。小鼠模型技術對於生物醫學研究非常有益。基因工程用於開發不同類型的小鼠模型，以針對特定的人類狀況。

市場動態：

基因編輯工具的進步以及人類和小鼠之間生理相似性的提高是增加對小鼠模型技術需求的主要因素。不利的一面是，各國政府實施的嚴格法規和指導方針以及一些組織對小鼠測試的日益反對可能會限制市場擴張。儘管如此，對人性化小鼠模型的需求不斷成長以及個性化醫療消費的增加可能會對小鼠模型技術市場產生積極影響。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球小鼠模型技術市場的每個細分市場進行了包容性評估。小鼠模型技術行業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的小鼠模型技術市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。小鼠模型技術市場的主要參與者包括Biocytogen、Charles River Laboratories、Cyagen Biosciences、Gempharmatech、genOway、ingenious Targeting Laboratory、Merck KGaA、Ozgene Pty Ltd.、Taconic Biosciences Inc.、PolyGene AG、The Jackson 實驗室、耶魯大學醫學院醫學，北卡羅來納大學，內布拉斯加大學醫學中心，莫納什大學，麻省大學陳醫學院，波恩大學，哥倫比亞大學，亞利桑那大學。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家/地區銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家/地區銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家/地區銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：MICE 模型技術公司的競爭格局

小鼠模型技術市場競賽
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市場佔有率分析
市場集中度
Biocytogen

公司簡介
公司收入
產品
最近的發展

Charles River Laboratories

公司簡介
公司收入
產品
最近的發展

Cyagen Biosciences

公司簡介
公司收入
產品
最近的發展

Gempharmatech

公司簡介
公司收入
產品
最近的發展

genOway

公司簡介
公司收入
產品
最近的發展

ingenious targeting laboratory

公司簡介
公司收入
產品
最近的發展

Merck KGaA

公司簡介
公司收入
產品
最近的發展

Ozgene Pty Ltd.

公司簡介
公司收入
產品
最近的發展

Taconic Biosciences Inc.

公司簡介
公司收入
產品
最近的發展

PolyGene AG

公司簡介
公司收入
產品
最近的發展

The Jackson laboratory

公司簡介
公司收入
產品
最近的發展

Yale School of Medicine

公司簡介
公司收入
產品
最近的發展

University of North Carolina

公司簡介
公司收入
產品
最近的發展

University of Nebraska Medical Center

公司簡介
公司收入
產品
最近的發展

Monash University

公司簡介
公司收入
產品
最近的發展

UMass Chan Medical School

公司簡介
公司收入
產品
最近的發展

University of Bonn

公司簡介
公司收入
產品
最近的發展

Columbia University

公司簡介
公司收入
產品
最近的發展

The University of Arizona

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11219536

The global demand for Mice Model Technologies Market is presumed to reach the market size of nearly USD 12.52 BN by 2030 from USD 5.04 BN in 2022 with a CAGR of 10.64% under the study period 2023 - 2030.

Mice model technologies use different mice species in order to mimic characteristics of a biological process or a disease found in humans. These technologies have become popular because mice share mammalian features with humans and suffer from many similar diseases. Mice model technologies are highly beneficial for biomedical research. Genetic engineering is used to develop different types of mice models to target specific human conditions.

MARKET DYNAMICS:

The rise in the advancements in gene editing tools and physiological similarities between humans and mice are major factors augmenting the demand for mice model technologies. On the downside, strict regulations and guidelines imposed by various governments and growing opposition to mice testing by several organizations may restrict market expansion. Nonetheless, rising demand for humanized mouse models and increasing consumption of personalized medicine will likely impact the mice model technologies market positively.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mice model technologies. The growth and trends of mice model technologies industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the mice model technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

CRISPR Knockout
CRISPR Knockin
Random Insertions
Large, Targeted Insertions
ES Cell Modification (Homologous Recombination)
Others

By End-User

Pharmaceutical Companies
Biotechnology Companies
Academic And Research Facilities
Contract Research And Manufacturing Organizations

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Mice Model Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mice model technologies market include Biocytogen, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Merck KGaA, Ozgene Pty Ltd., Taconic Biosciences Inc., PolyGene AG, The Jackson laboratory, Yale School of Medicine, University of North Carolina, University of Nebraska Medical Center, Monash University, UMass Chan Medical School, University of Bonn, Columbia University, The University of Arizona. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . MICE MODEL TECHNOLOGIES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By End-user
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 CRISPR Knockout Historic and Forecast Sales by Regions
6.5 CRISPR Knockin Historic and Forecast Sales by Regions
6.6 Random Insertions Historic and Forecast Sales by Regions
6.7 Large, Targeted Insertions Historic and Forecast Sales by Regions
6.8 ES Cell Modification (Homologous Recombination) Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
7.5 Biotechnology Companies Historic and Forecast Sales by Regions
7.6 Academic And Research Facilities Historic and Forecast Sales by Regions
7.7 Contract Research And Manufacturing Organizations Historic and Forecast Sales by Regions

8 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MICE MODEL TECHNOLOGIES COMPANIES

9.1. Mice Model Technologies Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF MICE MODEL TECHNOLOGIES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Biocytogen
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Charles River Laboratories
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Cyagen Biosciences
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Gempharmatech
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. genOway
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. ingenious targeting laboratory
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Merck KGaA
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Ozgene Pty Ltd.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Taconic Biosciences Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. PolyGene AG
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. The Jackson laboratory
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Yale School of Medicine
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. University of North Carolina
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. University of Nebraska Medical Center
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments
10.17. Monash University
- 10.17.1. Company Overview
- 10.17.2. Company Revenue
- 10.17.3. Products
- 10.17.4. Recent Developments
10.18. UMass Chan Medical School
- 10.18.1. Company Overview
- 10.18.2. Company Revenue
- 10.18.3. Products
- 10.18.4. Recent Developments
10.19. University of Bonn
- 10.19.1. Company Overview
- 10.19.2. Company Revenue
- 10.19.3. Products
- 10.19.4. Recent Developments
10.20. Columbia University
- 10.20.1. Company Overview
- 10.20.2. Company Revenue
- 10.20.3. Products
- 10.20.4. Recent Developments
10.21. The University of Arizona
- 10.21.1. Company Overview
- 10.21.2. Company Revenue
- 10.21.3. Products
- 10.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Technology (USD MN)
CRISPR Knockout Market Sales by Geography (USD MN)
CRISPR Knockin Market Sales by Geography (USD MN)
Random Insertions Market Sales by Geography (USD MN)
Large, Targeted Insertions Market Sales by Geography (USD MN)
ES Cell Modification (Homologous Recombination) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis Market by End-user (USD MN)
Pharmaceutical Companies Market Sales by Geography (USD MN)
Biotechnology Companies Market Sales by Geography (USD MN)
Academic And Research Facilities Market Sales by Geography (USD MN)
Contract Research And Manufacturing Organizations Market Sales by Geography (USD MN)
Global Mice Model Technologies Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Mice Model Technologies Report
Market Research Process
Market Research Methodology
Global Mice Model Technologies Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Technology
Market Attractiveness Analysis by End-user
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Technology (USD MN)
CRISPR Knockout Market Sales by Geography (USD MN)
CRISPR Knockin Market Sales by Geography (USD MN)
Random Insertions Market Sales by Geography (USD MN)
Large, Targeted Insertions Market Sales by Geography (USD MN)
ES Cell Modification (Homologous Recombination) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by End-user (USD MN)
Pharmaceutical Companies Market Sales by Geography (USD MN)
Biotechnology Companies Market Sales by Geography (USD MN)
Academic And Research Facilities Market Sales by Geography (USD MN)
Contract Research And Manufacturing Organizations Market Sales by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Top Companies Market Share Analysis